Quest Diagnostics Women’s Health

Successful treatment for cervical cancer often relies on early detection and treatment: the 5-year relative survival rate for the treatment of cervical cancer detected early is over 90%.1 However, gaps in screening and access in care persists as 50% of all new cervical cancers are diagnosed in women who have never been screened or have not been screened in the previous 5 years.2 Quest Diagnostics is proud to introduce HPV patient self-collection as part of our cervical cancer screening portfolio, which already includes co-testing and HPV primary testing. Learn more about our cervical cancer screening portfolio at questwomenshealth.com References: 1. American Cancer Society. Survival rates for cervical cancer. Last updated January 16, 2025. Accessed March 3, 2025. https://lnkd.in/gidkdWcw 2. Subramaniam A, Fauci JM, Schneider KE, et al. Invasive cervical cancer and screening: What are the rates of unscreened and underscreened women in the modern era? J Low Genit Tract Dis. 2011;15(2):110-113. doi:10.1097/LGT.0b013e3181f515a2

The recent FDA approval of patient self-collection as a modality for human papillomavirus (HPV) screening underscores the importance of improving testing rates, especially in populations with traditionally high unmet health needs. As part of our commitment to increased access to vital testing, Quest Diagnostics will soon add HPV patient self-collection to our comprehensive women’s and reproductive health portfolio. Visit www.questwomenshealth.com to learn more about all of our testing options and continue following us for more information as we prepare to launch HPV patient self-collection.

More than 50% of new cervical cancers were diagnosed in women who have never been screened or have not been screened in the previous 5 years.1 Detecting cervical cancer earlier through regular screening can be the best way to treat it. To learn more about our commitment to ensuring every woman is screened, visit us at https://lnkd.in/ew8D5mUX #CervicalCancerAwarenessMonth Reference: 1. Subramaniam A, Fauci JM, Schneider KE, et al. Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?. J Low Genit Tract Dis. 2011;15(2):110-113. doi:10.1097/LGT.0b013e3181f515a2

This January, we recognize #CervicalCancerAwarenessMonth. We are committed to supporting healthcare providers with research and tools to help detect cervical cancer and precancerous conditions. Regular screening is integral to the early detection and successful treatment of cervical cancer. Learn more about Quest’s cervical cancer screening options here: https://lnkd.in/ew8D5mUX

“In my role as a Genomic Science Specialist at Quest Diagnostics, my team and I speak to patients every day about their results. The most important part of our job is to listen carefully and empathetically to questions and concerns,” says Julia Wilkinson, of the Quest Women’s and Reproductive Health team.? ? Supporting clinicians by providing patients the proper guidance when seeking prenatal genetic screening is what our Genomic Client Services team does best. ? ? Read more about Julia’s perspective and learn more about the top questions your patients ask our team in this feature. #GeneticCounselorAwarenessDay #GeneChat?

As a part of National Genetic Counselor Awareness Day, we are honored to share appreciation for these genetic counselors and Genomic Science Specialists from those who work closely with them. Senior Vice President and Chief Medical Officer Dr Yuri Fesko, shares his insights on how vital it is to have genetic counselors involved in the patient journey and here at Quest. Read his testimonial below. #GeneticCounselorAwarenessDay

On this #GeneticCounselorAwarenessDay, we celebrate the genetic counselors and Genomic Science Specialists across our Genomic Client Services team for all they do to support patients and providers, today and every day. Our team members are key resources in navigating a patient’s health journey, in assisting physicians with complex cases, and in cultivating the next generation of genetic counselors through our student rotational training program. Learn more about their work at https://lnkd.in/eMT2_DZw #Genechat

Today, we are proud to recognize Michelle Hoard. Michelle’s commitment to supporting families through their fertility journey began early in her career. With a focus on leveraging genetic testing, family history, and fetal ultrasound findings, Michelle helps patients understand how these tools help to inform decisions about their pregnancy. In her role as a genetic counselor at Quest, she provides laboratory support with a focus on molecular genetic testing, carrier screening, and fetal testing. Learn more about the work Michelle does with the Women’s Health team at https://lnkd.in/eMT2_DZw #GeneticCounselorAwarenessDay #Genechat

All month long, we will be recognizing the important work of our Genomic Science Specialists, starting with Tessa Niemchak. Tessa is a member of our Women’s and Reproductive Health team at Quest with a focus on fertility services, including our QNatal? noninvasive prenatal screening test. As she has navigated her time in this role, Tessa has grown to love the insights technology can provide to patients who are considering pregnancy. Her passion for genetics and desire to work with people is at the center of what she does every day. Learn more about how Tessa, along with members of her team, are making a difference at Quest at https://lnkd.in/eMT2_DZw #GeneticCounselorAwarenessDay #Genechat

November 14 is Genetic Counselor Awareness Day, and we are excited to shine a spotlight all month long on our genetic counselors and Genomic Science Specialists across our specialty areas. These specialists play a vital role in the experiences of patients and supporting the providers who are navigating the complexity of genetic screening. Join us all month as we recognize and celebrate their hard work. Learn more about our Genomic Science Specialists at https://lnkd.in/esyFCeZ7 #GeneticCounselorAwarenessDay #Genechat